Literature DB >> 2482565

Characterization of laboratory working standard for quality control of immunometric and radiometric estrogen receptor assays. Clinical evaluation on breast cancer biopsies. Italian Committee for Hormone Receptor Assays Standardization.

A Piffanelli1, D Pelizzola, G Giovannini, L Catozzi, L Faggioli, M Giganti.   

Abstract

The objective of the study was to characterize a low-cost and reliable working standard material for quality control of estrogen receptor (ER) determination with dextran-coated charcoal (DCC) and enzyme immunoassay (EIA) methods. Human fibromatous uterine lyophilized cytosol demonstrated good characteristics of stability and applicability for this purpose. Eleven laboratories participated in the intralaboratory and interlaboratory quality control study, and they achieved slightly higher coefficients of variation for ER-EIA (interlaboratory, 37.7%; intralaboratory, 22.9%) than for ER-DCC (interlaboratory, 24.2%; intralaboratory, 15.7%). There was an excellent correlation between ER results with ER-EIA and ER-DCC for 268 breast cancer biopsies. Quality assurance for ER assays using DCC techniques and immunometric methods with monoclonal antibodies (ER-EIA) can be set up with this available material of human origin to satisfy the characteristics of both techniques and the species specificity of monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482565     DOI: 10.1177/030089168907500607

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  7 in total

1.  GnRH receptors in human breast cancer and its contiguous not-involved breast tissue.

Authors:  A Paradiso; A Pezzetta; G Cellamare; F Schittulli; F Marzullo; S J Reshkin
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

2.  Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.

Authors:  S Veneroni; M G Daidone; G Di Fronzo; V Cappelletti; D Amadori; A Riccobon; A Paradiso; M Correale; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

3.  Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer.

Authors:  A Paradiso; A Mangia; A Barletta; A M Catino; A Giannuzzi; F Schittulli; N Radogna; S Longo; D Palmieri; F Marzullo
Journal:  Drugs       Date:  1993       Impact factor: 9.546

4.  Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia.

Authors:  A Paradiso; A Mangia; M Correale; I Abbate; G Ferri; A Piffanelli; L Catozzi; D Amadori; A Riccobon; M De Lena
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  pS2--a new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer.

Authors:  M Correale; I Abbate; A Paradiso; F Schittulli; C D Dragone; T Tedone; G Gargano; A M Catino; M D Musci; M De Lena
Journal:  Cell Biophys       Date:  1993 Jan-Jun

6.  Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence.

Authors:  D Coradini; C Pellizzaro; S Veneroni; L Ventura; M G Daidone
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

7.  Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women.

Authors:  M G Daidone; A Luisi; G Martelli; E Benini; S Veneroni; G Tomasic; G De Palo; R Silvestrini
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.